BI 653048 phosphate

Modify Date: 2024-01-10 06:41:56

BI 653048 phosphate Structure
BI 653048 phosphate structure
Common Name BI 653048 phosphate
CAS Number 1198784-97-2 Molecular Weight 613.517
Density N/A Boiling Point N/A
Molecular Formula C23H28F4N3O8PS Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BI 653048 phosphate


An oral glucocorticoid agonist for the treatment of rheumatoid arthritis. Rheumatoid Arthritis Phase 1 Clinical

 Names

Name BI-653048

 BI 653048 phosphate Biological Activity

Description An oral glucocorticoid agonist for the treatment of rheumatoid arthritis. Rheumatoid Arthritis Phase 1 Clinical
Related Catalog
Target

CYP1A2:50 μM (IC50)

CYP2D6:41 μM (IC50)

CYP2C9:12 μM (IC50)

CYP2C19:9 μM (IC50)

CYP3A4:8 μM (IC50)

In Vitro BI 653048 phosphate exhibits an improved drug-like properties, inhibits CP1A2 ,CYP2D6 ,CYP2C9, CYP2C19 and CYP3A4 with IC50 values of 50 µM, 41 µM, 12 µM, 9 µM,and 8 µM, respectively[2]. BI 653048 phosphate reduces affinity for the hERG ion channel with an IC50>30 μM in recombinant HEK293 cells expressing the human ERG potassium channel[2]. BI 653048 phosphate inhibits TNF-stimulated IL-6 production in mouse RAW cells with an IC50 value of 100 nM[2].
In Vivo BI 653048 phosphate (oral administration; 3, 10, and 30 mg/kg) at 3 mg/kg has nonsignificant decreases for all measured histology parameters (ankle inflammation, pannus formation, cartilage damage, and bone resorption), Mid-dose (10 mg/kg) treatment significantly decreases pannus and bone resorption (33%) as well as summed scores (27%), while at high dose (30 mg/kg), all parameters are significantly decreased (87–96%). The ED50 value for the summed scores is 14 mg/kg[2]. Animal Model: Mice[2] Dosage: 3, 10, and 30 mg/kg Administration: Oral administration Result: Exhibited significant decreases for all measured histology parameters at high doses.
References

[1]. Reeves JT, et al. Development of a large scale asymmetric synthesis of the glucocorticoid agonist BI 653048 BS H3PO4.J Org Chem. 2013 Apr 19;78(8):3616-35.

[2]. Harcken C, et al. Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.ACS Med Chem Lett. 2014 Nov 20;5(12):1318-23.

[3]. Montse Llinas-Brunet, et al. Latest bibliographic data on file with the International Bureau

 Chemical & Physical Properties

Molecular Formula C23H28F4N3O8PS
Molecular Weight 613.517
InChIKey DPIBBVZDLOOJRM-FTBISJDPSA-N
SMILES CCS(=O)(=O)c1cc2cc(CC(O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1.O=P(O)(O)O
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

BI 653048 phosphate suppliers

BI 653048 phosphate price